Abstract:Selective Mcl-1 inhibitors may overcome the drug resistance caused by current anti-apoptotic Bcl-2 protein inhibitors in tumors with Mcl-1 overexpression. Based on previously discovered compounds with a 3-phenylthiophene-2-sulfonamide core moiety, in this work, we have obtained new compounds with improved binding affinity and/or selectivity under the guidance of structure-based design. The most potent compounds achieved sub-micromolar binding affinities to Mcl-1 (Ki ∼ 0.4 μM) and good cytotoxicity (IC50 < 10 μM) on several tumor cells. 15N-heteronuclear single-quantum coherence NMR spectra suggested that these compounds bound to the BH3-binding groove on Mcl-1. Several cellular assays revealed that FWJ-D4 as well as its precursor FWJ-D5 effectively induced caspase-dependent apoptosis, and their target engagement at Mcl-1 was confirmed by co-immunoprecipitation experiments. Treatment with FWJ-D5 at 50 mg/kg every 2 days on an RS4;11 xenograft mouse model for 22 days led to 75% reduction in tumor volume without body weight loss.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00690?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00690</a>.Information of the predicted hydration sites in the Mcl-1 binding pocket, flow cytometric analysis of three selected compounds, and HPLC traces for the reported compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00690/suppl_file/jm1c00690_si_001.pdf">PDF</a>)Molecular formula strings of all reported compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00690/suppl_file/jm1c00690_si_002.csv">CSV</a>)Structural files of the predicted binding modes of YCW-E10 and FWJ-D4 with Mcl-1 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00690/suppl_file/jm1c00690_si_003.zip">ZIP</a>)Statement on the ethnicity of all animal experiments performed in this work (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00690/suppl_file/jm1c00690_si_004.pdf">PDF</a>)This article has not yet been cited by other publications.

Structure‐based Design, Synthesis, and Evaluation of Bcl‐2/Mcl‐1 Dual Inhibitors

Design, Synthesis, And Interaction Study Of Quinazoline-2(1h)-Thione Derivatives As Novel Potential Bcl-X(L) Inhibitors

Structure-Based Optimization of 3-Phenyl-<i>N</i>-(2-(3-phenylureido)ethyl)thiophene-2-sulfonamide Derivatives as Selective Mcl-1 Inhibitors

Structure-Based Optimization of 3-Phenyl- N -(2-(3-phenylureido)ethyl)thiophene-2-sulfonamide Derivatives as Selective Mcl-1 Inhibitors

Extracellular polymeric substances from copper-tolerance Sinorhizobium meliloti immobilize Cu²⁺.

Development of 3‐phenyl‐n‐(2‐(3‐phenylureido)ethyl)‐thiophene‐2‐sulfonamide Compounds As Inhibitors of Antiapoptotic Bcl‐2 Family Proteins

De novo design, synthesis and evaluation of benzylpiperazine derivatives as highly selective binders of Mcl-1.

Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins.

Structure-Based Design Of Flavonoid Compounds As A New Class Of Small-Molecule Inhibitors Of The Anti-Apoptotic Bcl-2 Proteins

Discovery and optimization of (2-naphthylthio)acetic acid derivative as selective Bfl-1 inhibitor

Design, Synthesis and Pharmacological Evaluation of New Acyl Sulfonamides As Potent and Selective Bcl-2 Inhibitors.

Discovery of 3,5-Dimethyl-4-Sulfonyl-1 H -Pyrrole-Based Myeloid Cell Leukemia 1 Inhibitors with High Affinity, Selectivity, and Oral Bioavailability

Discovery and Development of Thiazolo[3,2-a]pyrimidinone Derivatives As General Inhibitors of Bcl-2 Family Proteins

Discovery of Mcl-1 inhibitors through virtual screening, molecular dynamics simulations and in vitro experiments

Discovery of Novel Mcl-1 Inhibitors with a 3-Substituted-1 H-indole-1-yl Moiety Binding to the P1-P3 Pockets to Induce Apoptosis in Acute Myeloid Leukemia Cells

Design, Synthesis and Biological Evaluation of (R)-5-methylpyrrolidin-2-ones As P300 Bromodomain Inhibitors with Anti-Tumor Activities in Multiple Tumor Lines.

Design, synthesis and preliminary bioactivity studies of imidazolidine-2,4-dione derivatives as Bcl-2 inhibitors.

Structure-Based Discovery of MDM2/4 Dual Inhibitors that Exert Antitumor Activities against MDM4-Overexpressing Cancer Cells

Discovery of Phenylpyrazole Derivatives As a New Class of Selective Inhibitors of MCL-1 with Antitumor Activity

Design, Synthesis, Chemical and Biochemical Insights Into Novel Hybrid Spirooxindole-Based p53-MDM2 Inhibitors With Potential Bcl2 Signaling Attenuation

Synthesis of 4‐(2‐phenylhydrazono)‐1‐(4‐phenylthiazol‐2‐yl)‐1h‐pyrazol‐5(4h)‐one Compounds and Characterization of Their Affinities to Anti‐apoptotic Bcl‐2 Family Proteins